Weiss Ratings Reiterates “Hold (C)” Rating for Option Care Health (NASDAQ:OPCH)

Option Care Health (NASDAQ:OPCH)‘s stock had its “hold (c)” rating reiterated by equities researchers at Weiss Ratings in a note issued to investors on Saturday,Weiss Ratings reports.

Several other research analysts have also weighed in on OPCH. Cowen began coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating on the stock. TD Cowen began coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating and a $30.00 price objective on the stock. JMP Securities upped their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “market outperform” rating in a research note on Thursday, July 31st. Morgan Stanley began coverage on shares of Option Care Health in a research note on Friday, October 17th. They issued an “overweight” rating and a $35.00 price objective on the stock. Finally, Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Tuesday, September 23rd. Nine equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $35.10.

Option Care Health Stock Down 0.5%

OPCH stock opened at $27.91 on Friday. Option Care Health has a 52-week low of $21.39 and a 52-week high of $35.53. The company’s 50 day simple moving average is $27.99 and its 200-day simple moving average is $30.09. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The firm has a market capitalization of $4.53 billion, a P/E ratio of 22.33, a P/E/G ratio of 1.69 and a beta of 0.88.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company’s revenue for the quarter was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, equities research analysts anticipate that Option Care Health will post 1.22 EPS for the current year.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were acquired at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the purchase, the director owned 375,390 shares of the company’s stock, valued at $10,191,838.50. This represents a 10.61% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Norman L. Wright bought 3,411 shares of the stock in a transaction that occurred on Tuesday, September 9th. The stock was purchased at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the completion of the purchase, the director directly owned 15,501 shares in the company, valued at $454,334.31. The trade was a 28.21% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 59,411 shares of company stock worth $1,627,576 in the last 90 days. 0.64% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Teton Advisors Inc. boosted its holdings in Option Care Health by 2.2% in the 2nd quarter. Teton Advisors Inc. now owns 17,368 shares of the company’s stock valued at $564,000 after purchasing an additional 368 shares during the period. US Bancorp DE boosted its holdings in Option Care Health by 5.0% in the 1st quarter. US Bancorp DE now owns 8,199 shares of the company’s stock valued at $287,000 after purchasing an additional 393 shares during the period. Assetmark Inc. boosted its holdings in Option Care Health by 1.6% in the 2nd quarter. Assetmark Inc. now owns 26,690 shares of the company’s stock valued at $867,000 after purchasing an additional 416 shares during the period. State of Wyoming boosted its holdings in Option Care Health by 1.8% in the 2nd quarter. State of Wyoming now owns 25,135 shares of the company’s stock valued at $816,000 after purchasing an additional 436 shares during the period. Finally, Sheets Smith Wealth Management boosted its holdings in Option Care Health by 1.9% in the 2nd quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company’s stock valued at $810,000 after purchasing an additional 457 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.